| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Brazil | 2 | |
| #2 | Canada | 2 | |
| #3 | China | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | France | 2 | |
| #6 | United States | 2 | |
| #7 | WIPO (World Intellectual Property Organization) | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bonnafous Ludovic | 12 |
| #2 | Laruelle Claude | 12 |
| #3 | Claude Laruelle | 2 |
| #4 | Ludovic Bonnafous | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CN110234317A | With the double action for treating obesity relevant to nonalcoholic fatty liver disease (NASH) and hypertriglyceridemia according to Rabat melbine salt | |
| FR3056909A1 | COMPOSITION COMPRISING AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE SALT OF SOLUBLE ELAFIBRANOR IN AQUEOUS MEDIA HAVING IMPROVED INTESTINAL ABSORPTION |